PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia.

Cole CB, Verdoni AM, Ketkar S, Leight ER, Russler-Germain DA, Lamprecht TL, Demeter RT, Magrini V, Ley TJ

Open source

DOI
10.1172/jci82897
Published
2016 Jan
Container
The Journal of clinical investigation
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1172/jci82897,
  title = {PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia.},
  author = {Cole CB and Verdoni AM and Ketkar S and Leight ER and Russler-Germain DA and Lamprecht TL and Demeter RT and Magrini V and Ley TJ},
  year = {2016},
  journal = {The Journal of clinical investigation},
  doi = {10.1172/jci82897},
  url = {https://doi.org/10.1172/jci82897}
}

RIS

TY  - JOUR
TI  - PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia.
AU  - Cole CB
AU  - Verdoni AM
AU  - Ketkar S
AU  - Leight ER
AU  - Russler-Germain DA
AU  - Lamprecht TL
AU  - Demeter RT
AU  - Magrini V
AU  - Ley TJ
PY  - 2016
JO  - The Journal of clinical investigation
DO  - 10.1172/jci82897
UR  - https://doi.org/10.1172/jci82897
ER  - 

APA

CB, C., AM, V., S, K., ER, L., DA, R., TL, L., RT, D., V, M., & TJ, L. (2016). PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia.. The Journal of clinical investigation. https://doi.org/10.1172/jci82897

Source records